Physician

Maira Paschoin De Oliveira Campos, M.D.

According to 2025 Medicare claims, Maira Campos, M.D. (NPI: 1497020861) practices hematology/oncology in the Santa Maria-Santa Barbara, CA market, with the plurality of this provider's patient population coming from Santa Barbara, CA. This provider's primary affiliated billing organization is SANSUM CLINIC (NPI: 1932121514; TIN: 956419205) and primary practice location at 93105-4230. Campos is affiliated with the Aledade A3299 CA MSSP Enhanced (ACO ID: A3299), participating under the MSSP model.

Campos' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 480 traditional Medicare patients, billed 139,800 HCPCS/CPT codes, and received $2,274,037 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,988 prescription claims across 341 beneficiaries totaling $2,427,416 in drug costs, led by Verzenio (Abemaciclib). DME data shows 61 claims. Open Payments data shows 59 records totaling $38,366. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $248,372 and ending at $2,274,037. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $8,330 to $2,427,416. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	124	14,806	$248,372
2019	327	72,945	$1,047,325
2020	227	861	$68,714
2021	279	17,413	$140,366
2022	341	91,433	$754,970
2023	428	115,022	$1,281,973
2024	480	139,800	$2,274,037

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	45	$8,330
2016	N/R	11	$7,761
2017	N/R	N/R	N/R
2018	34	96	$54,749
2019	101	409	$541,684
2020	141	813	$931,443
2021	152	787	$1,177,909
2022	182	647	$503,027
2023	258	1,176	$1,499,505
2024	341	1,988	$2,427,416

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	24	$716
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	61	$1,210

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	279	510	$141
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	171	305	$102
99443	Telephone medical discussion with physician, 21-30 minutes	176	263	$99
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	72	125	$54
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	163	207	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Verzenio	Abemaciclib	63	1,774	$875,980
Ibrance	Palbociclib	20	544	$300,475
Lenalidomide	Lenalidomide	17	476	$232,452
Erleada	Apalutamide	14	420	$202,946
Eliquis	Apixaban	64	2,790	$53,571

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J8521	Capecitabine, oral, 500 mg	N	N/R	28	$658
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	22	$414
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	11	$138

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	6	$159	Lilly USA, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	53	$38,208	Genentech, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Maira Paschoin De Oliveira Campos, M.D.?

Tedicare shows public-source Medicare data for Maira Paschoin De Oliveira Campos, M.D. (NPI 1497020861), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Maira Paschoin De Oliveira Campos, M.D. have ACO affiliation data?

Maira Paschoin De Oliveira Campos, M.D. is shown with ACO affiliation data for Aledade A3299 CA MSSP Enhanced (MSSP, ACO ID A3299).

What billing organization is linked to Maira Paschoin De Oliveira Campos, M.D.?

Maira Paschoin De Oliveira Campos, M.D. is linked to SANSUM CLINIC (billing NPI 1932121514) in the available physician profile data.

Does Maira Paschoin De Oliveira Campos, M.D. have Open Payments data?

Maira Paschoin De Oliveira Campos, M.D. has 59 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.